MENU

EVH Stock Evolent Health (EVH, $8.65) entered Uptrend as Momentum indicator ascends above 0 level on Jun 18, 2025

A.I.dvisor
at Tickeron.com
Loading...
EVH - Evolent Health
Momentum signal
Bullish Trend
Odds of UP Trend
Tickeron
Momentum signal
Price: $8.65
Daily change: +$0.16 (+1.88%)
Daily volume: 1.7M
Capitalization: $1B
Industry: Packaged Software
This indicator may be signaling that EVH's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. A.I.dvisor backtested 87 similar cases where EVH's Momentum Indicator exceeded 0, and of them led to a successful outcome. Odds of Success:

Momentum Indicator for EVH turns positive, indicating new upward trend

EVH saw its Momentum Indicator move above the 0 level on June 18, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EVH just turned positive on June 04, 2025. Looking at past instances where EVH's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

EVH moved above its 50-day moving average on June 20, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EVH crossed bullishly above the 50-day moving average on June 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EVH advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 258 cases where EVH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EVH broke above its upper Bollinger Band on June 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EVH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.406) is normal, around the industry mean (31.764). P/E Ratio (0.000) is within average values for comparable stocks, (163.927). Projected Growth (PEG Ratio) (1.928) is also within normal values, averaging (2.724). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (1.809) is also within normal values, averaging (61.726).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
EVH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of transformation solutions to health systems

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
1812 N. Moore Street
Phone
+1 571 389-6000
Employees
4700
Web
https://www.evolenthealth.com